SCHEMBL2384472

SCHEMBL2384472

O=Cc1cc(-c2cc(Cl)ccn2)cs1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 1/20 0.38
MAP4K4 O95819 1/20 0.36
PTGS1 P23219 1/20 0.34
PTGS2 P35354 1/20 0.34
CYP19A1 P11511 2/20 0.33
CCNC P24863 1/20 0.33
CDK8 P49336 1/20 0.33
ALDH1A1 P00352 1/20 0.33
MAPT P10636 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
PGR P06401 1/20 0.32
KMO O15229 1/20 0.32
CYP2A6 P11509 2/20 0.32
CCR1 P32246 1/20 0.32
CCR5 P51681 1/20 0.32
CCR8 P51685 1/20 0.32
MAPKAPK2 P49137 2/20 0.32
CNR1 P21554 2/20 0.31
HSD17B1 P14061 1/20 0.31
HSD17B2 P37059 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2382655 0.84 PIM1 (0.38) PIM1MAP4K4PTGS1PTGS2CYP19A1
SCHEMBL1098764 0.79 CYP2A6 (0.34) PIM1CYP19A1CCNCCDK8ALDH1A1
SCHEMBL2557769 0.77 KDM5C (0.54) ALDH1A1MAPTKMO
SCHEMBL6193707 0.77 CYP2A6 (0.44) CYP19A1ALDH1A1MAPTL3MBTL1CYP2A6
SCHEMBL2385156 0.74 ALAD (0.42) PIM1MAP4K4PTGS1PTGS2ALDH1A1
SCHEMBL2382865 0.74 PIM1 (0.36) PIM1MAP4K4PTGS1PTGS2CYP19A1
SCHEMBL6850861 0.73 PIM2 (0.38) PIM1CYP19A1CCNCCDK8ALDH1A1
SCHEMBL1108278 0.73 KDM4E (0.45) ALDH1A1MAPTL3MBTL1PGRCYP2A6
SCHEMBL12177559 0.72 ALAD (0.53) ALDH1A1MAPTL3MBTL1PGRCNR1
SCHEMBL2385102 0.71 KDM4C (0.37) PIM1MAP4K4PTGS1PTGS2CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8022209-B2 Substituted nitrogen-containing heteroaryl derivatives useful as modulators of the histamine H4 receptor JANSSEN PHARMACEUTICA NV (BE) 2011-09-20 US disclosed
WO-2009035671-A1 SUBSTITUTED NITROGEN-CONTAINING HETEROARYL DERIVATIVES USEFUL AS MODULATORS OF THE HISTAMINE H4 RECEPTOR JANSSEN PHARMACEUTICA N.V. (BE) 2009-03-19 WO disclosed
US-20090069305-A1 Substituted nitrogen-containing heteroaryl derivatives useful as modulators of the histamine H4 receptor JANSSEN PHARMACEUTICA N.V. (BE) 2009-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069305-A1 Substituted nitrogen-containing heteroaryl derivatives useful as modulators of the histamine H4 receptor HRH4, HRH3, HRH2 PIM1 4865/4885MAP4K4 2457/4885PTGS1 827/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.